Stockreport

LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF In the study, muvalaplin led to a significant reduction in elevated Lp(a) levels compared to placebo, meeting the study's primary endpoint of percent change in Lp(a) fr [Read more]